CRISPR/Cas9-Mediated Genome Editing of Mouse Small Intestinal Organoids

Gerald Schwank, Hans Clevers

Research output: Contribution to journal/periodicalArticleScientificpeer-review

26 Citations (Scopus)


The CRISPR/Cas9 system is an RNA-guided genome-editing tool that has been recently developed based on the bacterial CRISPR-Cas immune defense system. Due to its versatility and simplicity, it rapidly became the method of choice for genome editing in various biological systems, including mammalian cells. Here we describe a protocol for CRISPR/Cas9-mediated genome editing in murine small intestinal organoids, a culture system in which somatic stem cells are maintained by self-renewal, while giving rise to all major cell types of the intestinal epithelium. This protocol allows the study of gene function in intestinal epithelial homeostasis and pathophysiology and can be extended to epithelial organoids derived from other internal mouse and human organs.

Original languageEnglish
Pages (from-to)3-11
Number of pages9
JournalMethods in Molecular Biology
Publication statusPublished - 2016


Dive into the research topics of 'CRISPR/Cas9-Mediated Genome Editing of Mouse Small Intestinal Organoids'. Together they form a unique fingerprint.

Cite this